Tumour burden at diagnosis as the main clinical predictor of cell resistance in patients with early stage, favourable Hodgkin lymphoma treated with VBM chemotherapy plus radiotherapy-Reference-Cited by-同舟云学术

Tumour burden at diagnosis as the main clinical predictor of cell resistance in patients with early stage, favourable Hodgkin lymphoma treated with VBM chemotherapy plus radiotherapy

Published:2012-10-29 Issue:3 Volume:31 Page:151-155
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematol Oncol

Author:

Gobbi Paolo G.¹,Bergonzi Manuela¹,Bassi Emilio²,Merli Francesco³,Coriani Chiara⁴,Federico Massimo⁵

Affiliation:

1. Medicina Interna e Gastroenterologia; Università di Pavia, Fondazione IRCCS Policlinico S. Matteo; Pavia Italy

2. Radiologia; Fondazione IRCCS Policlinico S. Matteo; Pavia Italy

3. Unità Operativa di Ematologia, Arcispedale ‘S. Maria Nuova’, IRCCS; Reggio Emilia Italy

4. Unità Operativa di Radiologia, Arcispedale ‘S. Maria Nuova’, IRCCS; Reggio Emilia Italy

5. Oncologia Medica; Università di Modena, Policlinico di Modena; Modena Italy

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Reference18 articles.

1. What has happened to VBM (vinblastine, bleomycin, and methotrexate) chemotherapy for early-stage Hodgkin lymphoma?;Gobbi;Crit Rev Oncol Hematol,2012

2. Image-aided estimate of tumor burden in Hodgkin's disease: evidence of its primary prognostic importance;Gobbi;J Clin Oncol,2001

3. The clinical value of tumor burden at diagnosis in Hodgkin lymphoma;Gobbi;Cancer,2004

4. Chemoresistance as a function of the pre-therapy tumor burden and the chemotherapy regimen administered;Gobbi;Clin Lymphoma Myeloma Leuk,2011

5. Tumor burden predicts treatment resistance in patients with early unfavorable or advanced-stage Hodgkin Lymphoma treated with ABVD and radiotherapy;Gobbi;Hematol Oncol

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Outcome of Hodgkin Lymphoma With Reference to Prognostic Markers;Cureus;2022-08-26

2. Total tumor burden in lymphoma – an evolving strong prognostic parameter;The British Journal of Radiology;2021-11-01

3. Prognostic Factors;Hodgkin Lymphoma;2020

4. Volumetric assessment of mediastinal lymphoma masses in Hodgkin lymphoma;Leukemia & Lymphoma;2019-06-22

5. Prognostic Factors;Hodgkin Lymphoma;2014-12-05